Cytion GmbH
About us
Cytion upholds its reputation as a trusted cell bank. We specialize in high-quality, contamination-free cells from humans and animals, ensuring rigorous quality control and authentication. Renowned for reliability, our cell lines are the go-to choice for researchers needing genetically authentic samples. With Cytion, experience ease and confidence in sourcing authentic cell culture solutions.
Founded in 2004 in Heidelberg, Germany as Cell Lines Service and rebranded as Cytion in 2023, the company has spent over two decades building one of the most extensive independent cell banks in the world. Today Cytion serves researchers and industry partners in more than 100 countries from its German headquarters and its US site in Sioux Falls, South Dakota.
Address
Nikola-Tesla-Straße 3
69124 Heidelberg
Germany
E-mail: h.schwegler@cytion.com
Phone: +49 6221 405781
Internet: www.cytion.com/
Contact person:
Products & Services
We offer cell lines, primary and stem cells, culture media, and cell culture services, built for research that needs to hold up on repeat.
Human cell lines
600+ authenticated human cell lines, from cancer models to hybridomas and reporter-labeled lines. Used for disease research, drug testing, and producing proteins or antibodies.
Animal cell lines
Authenticated lines from hamster, mouse, rat, dog, and other species. Common in virology, toxicology, and vaccine work.
Primary cells
Cells isolated directly from tissue, such as HUVECs, fibroblasts, and oral cells. They behave closer to real biology than immortalized lines.
Stem cells
Human mesenchymal stem cells from bone marrow and Wharton's Jelly, plus dental follicle stem cells. Used in regenerative medicine and drug development.
Growth & freezing media
Media for culturing and cryopreserving cells, keeping viability and results consistent from batch to batch.
Cell culture services
Master and Working Cell Bank production, sample storage, STR profiling, mycoplasma and viral testing, assay-ready cells, cell pellets, DNA/RNA extraction, and scale-up.